Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.22 USD | +2.93% | +1.94% | -23.45% |
May. 15 | Earnings Flash (MRKR) MARKER THERAPEUTICS Reports Q1 Revenue $1.2M | MT |
Apr. 30 | Ladenburg Thalmann Starts Marker Therapeutics With Buy Rating, $11 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.45% | 36.55M | |
+31.48% | 50.85B | |
+1.06% | 42.82B | |
+48.77% | 42.03B | |
-4.22% | 29.55B | |
+10.98% | 26.11B | |
-22.31% | 19.13B | |
+7.56% | 13.05B | |
+26.80% | 12.16B | |
+23.18% | 12.08B |
- Stock Market
- Equities
- MRKR Stock
- News Marker Therapeutics, Inc.
- Sector Update: Health Care